Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Sagent Pharmaceuticals, Inc. | Financial_Report.xls |
| EX-23.2 - EX-23.2 - Sagent Pharmaceuticals, Inc. | d305285dex232.htm |
| EX-31.2 - EX-31.2 - Sagent Pharmaceuticals, Inc. | d305285dex312.htm |
| EX-21.1 - EX-21.1 - Sagent Pharmaceuticals, Inc. | d305285dex211.htm |
| EX-31.1 - EX-31.1 - Sagent Pharmaceuticals, Inc. | d305285dex311.htm |
| EX-32.1 - EX-32.1 - Sagent Pharmaceuticals, Inc. | d305285dex321.htm |
| 10-K - 10-K - Sagent Pharmaceuticals, Inc. | d305285d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-175352) pertaining to the 2007 Global Share Plan of Sagent Holding Co. and the 2011 Incentive Compensation Plan of Sagent Pharmaceuticals, Inc. of our report dated March 29, 2012, with respect to the consolidated financial statements and schedule of Sagent Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2011.
/s/ Ernst & Young LLP
Chicago, Illinois
March 29, 2012